OACC
Oaktree Acquisition Corp. III Life Sciences
10.80$
+0.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | +2,986.1% | +72.5% | -158.0% | – | -85.9% | +106.3% | +173.4% | – | |
| – | – | -100.0% | – | – | -100.0% | – | – | – | |
| – | – | – | – | +76,696.1% | -99.9% | – | – | – | |
| – | – | – | – | +0.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | -105.6% | – | -299.6% | – | -248.9% | – | – | |
| – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.